The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease

Background and Aims Current tools for risk stratification of chronic liver disease subjects are limited. We aimed to determine whether the serum‐based ELF (Enhanced Liver Fibrosis) test predicted liver‐related clinical outcomes, or progression to advanced liver disease, and to compare the performanc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Liver international 2016-03, Vol.36 (3), p.370-377
Hauptverfasser:	Irvine, Katharine M., Wockner, Leesa F., Shanker, Mihir, Fagan, Kevin J., Horsfall, Leigh U., Fletcher, Linda M., Ungerer, Jacobus P. J., Pretorius, Carel J., Miller, Gregory C., Clouston, Andrew D., Lampe, Guy, Powell, Elizabeth E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Algorithms Biomarkers - blood Biopsy Chronic Disease Decision Support Techniques decompensation Disease Progression Female Humans Hyaluronic Acid - blood Liver - metabolism Liver - pathology liver cancer liver cirrhosis Liver Cirrhosis - blood Liver Cirrhosis - diagnosis Liver Cirrhosis - etiology Liver Cirrhosis - pathology Liver Diseases - complications Liver Diseases - diagnosis Male Middle Aged non-invasive biomarkers Peptide Fragments - blood prediction of clinical outcomes Predictive Value of Tests Procollagen - blood Reproducibility of Results Retrospective Studies Risk Factors Severity of Illness Index Time Factors Tissue Inhibitor of Metalloproteinase-1 - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!